Status:
RECRUITING
Prevención en Sus Manos: Feasibility of a Novel Community-Based Strategy to Improve Access to Cervical Cancer Screening
Lead Sponsor:
M.D. Anderson Cancer Center
Conditions:
HPV
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Cervical cancer is a disease that is preventable through vaccination against the virus that causes it, human papillomavirus (HPV), and through screening and treatment of cervical disease before it bec...
Detailed Description
Primary Objectives: The overall purpose of this protocol is to evaluate the feasibility and acceptability of CHW-delivered selfsample HPV testing (CHW-SS) to increase cervical cancer screening among ...
Eligibility Criteria
Inclusion
- To be eligible to participate in this study, an individual must meet all of the following criteria:
- Provision of signed and dated informed consent form
- Currently resident in RGV or other low-resource community in Texas
- Stated willingness to comply with all study procedures
- Females; Age ≥25 years
- Have no history of hysterectomy with removal of the cervix
- Have no history of cervical cancer or high-grade dysplasia
- Have not had a Pap test in the past 3.5 years or Pap/HPV co-test in the past 5.5 years.
Exclusion
- An individual who meets any of the following criteria will be excluded from participation in this study:
- Unable to communicate in English or Spanish
- Lack valid telephone contact information
- Report being currently pregnant.
Key Trial Info
Start Date :
October 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2030
Estimated Enrollment :
920 Patients enrolled
Trial Details
Trial ID
NCT06109870
Start Date
October 30 2023
End Date
August 31 2030
Last Update
September 15 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas at Austin
Austin, Texas, United States, 78712
2
M D Anderson Cancer Center
Houston, Texas, United States, 77030